Exact Mass: 474.2379
Exact Mass Matches: 474.2379
Found 500 metabolites which its exact mass value is equals to given mass value 474.2379
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Methylprednisolone succinate
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D000893 - Anti-Inflammatory Agents D000970 - Antineoplastic Agents D020011 - Protective Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Rubraflavone B
Rubraflavone B is found in fruits. Rubraflavone B is a constituent of Morus rubra (red mulberry)
Austalide B
Austalide B is a mycotoxin of. of the food storage mould Aspergillus ustu
Danusertib
Darexaban
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015842 - Serine Proteinase Inhibitors D006401 - Hematologic Agents > D000925 - Anticoagulants > D000991 - Antithrombins C78275 - Agent Affecting Blood or Body Fluid > C29750 - Thrombolytic Agent
Macimorelin
Methylprednisolone hemisuccinate
mTOR-IN-1
Saterinone
Methylprednisolone 17-hemisuccinate
Poinsettifolin B
5,7,4-trihydroxy-6,8-di(3-methylbut-2-enyl)-3-(1,1-dimethylallyl)isoflavone|fleminginin
3-beta-D-glucopyranosyl-6beta-hydroxyethinylestradiol
16-Ac-(3beta,5beta,14beta,15beta,16beta)-14,15-Epoxy-3,5,16,19-tetrahydroxybufa-20,22-dienolide
3-Ac-(3beta,5beta,11alpha,14beta)-3,5,11,14-Tetrahydroxy-12-oxobufa-20,22-dienolide
1-[6-(3,7-dimethylocta-2,6-dienyl)-5,7-dihydroxy-2,2-dimethyl-2H-chromen-8-yl]-3-(4-hydroxyphenyl)propenone|mallotophilippen C
5,7,4-trihydroxy-8,2,5-tri(3-methylbut-2-enyl)isoflavanone|strobiliferyllin
14(17)-dehydrocaesalmin F|14(17)-dehydrocaesalpin F
(2S)-5,7-dihydroxy-3,8-di(3-methyl-2-enyl)-2,2-dimethylpyrano[5,6:5,4]flavanone|maackiaflavanone B
5,7-dihydroxy-8-(2-methylbutanoyl)-6-[(E)-3,7-dimethylocta-2,6-dienyl]-4-phenyl-2H-chromen-2-one
(1S,4R,5S,6R,7S,8S,9R,10S)-1,8-diacetoxy-9-benzoyloxy-6-hydroxy-dihydro-beta-agarofuran
1,8,10-trihydroxy-6-methyl-4,5-bis-(3,3-dimethylallyl)-2,3-(2,2-dimethylpyrano)anthrone|kenganthranol E
(1alpha,2alpha,8beta,9beta)-1,8-bis(acetyloxy)-9-(benzoyloxy)-2-hydroxy-beta-dihydroagarofuran
5,7-dihydroxy-6-(3-methylbutanoyl)-8-[(E)-3,7-dimethylocta-2,6-dienyl]-4-phenyl-2H-chromen-2-one
1alpha-benzoyloxy-6beta,9beta-diacetoxy-4beta-hydroxydihydro-beta-agarofuran
5,7-dihydroxy-8-(3-methylbutanoyl)-6-[(E)-3,7-dimethylocta-2,6-dienyl]-4-phenyl-2H-chromen-2-one
5,7-dihydroxy-6-(2-methylbutanoyl)-8-[(E)-3,7-dimethylocta-2,6-dienyl]-4-phenyl-2H-chromen-2-one
(1S,4R,5S,6R,7R,8R,9S,10S)-6,8-diacetoxy-9-benzoyloxy-1-hydroxydihydro-beta-agarofuran
3,4,5-trimethoxy-benzoic acid 9-hydroxy-11-oxo-dodecahydro-7,14-methano-dipyrido[1,2-a;1,2-e][1,5]diazocin-2-yl ester|Catalaudesmin
3alpha-angeloyloxy-4beta,10beta-dihydroxy-8beta,17,15,16-bis-epoxy-cis-clerodane-13(16),14-dien-20,12-olide
Ile Val Glu Asp
Ile Asp Val Glu
Val Asn Asp Lys
Guajadial F
C26H34O8_(1R,2R,4S,16R,17R,20S)-2-Hydroxy-13,20-dimethoxy-4,7,17,22,22-pentamethyl-5,10,21,23-tetraoxahexacyclo[18.2.1.0~1,17~.0~4,16~.0~6,14~.0~8,12~]tricosa-6(14),7,12-trien-11-one
Ala Glu Lys Gln
Ala Glu Gln Lys
Ala Lys Glu Gln
Ala Lys Gln Glu
Ala Gln Glu Lys
Ala Gln Lys Glu
Cys Lys Pro Gln
Cys Lys Gln Pro
Cys Pro Lys Gln
Cys Pro Gln Lys
Cys Gln Lys Pro
Cys Gln Pro Lys
Asp Asp Ile Ile
Asp Asp Ile Leu
Asp Asp Leu Ile
Asp Asp Leu Leu
Asp Glu Ile Val
Asp Glu Leu Val
Asp Glu Val Ile
Asp Glu Val Leu
Asp Ile Asp Ile
Asp Ile Asp Leu
Asp Ile Glu Val
Asp Ile Ile Asp
Asp Ile Leu Asp
Asp Ile Val Glu
Asp Lys Asn Val
Asp Lys Val Asn
Asp Leu Asp Ile
Asp Leu Asp Leu
Asp Leu Glu Val
Asp Leu Ile Asp
Asp Leu Leu Asp
Asp Leu Val Glu
Asp Asn Lys Val
Asp Asn Val Lys
Asp Val Glu Ile
Asp Val Glu Leu
Asp Val Ile Glu
Asp Val Lys Asn
Asp Val Leu Glu
Asp Val Asn Lys
Glu Ala Lys Gln
Glu Ala Gln Lys
Glu Asp Ile Val
Glu Asp Leu Val
Glu Asp Val Ile
Glu Asp Val Leu
Glu Glu Val Val
Glu Ile Asp Val
Glu Ile Val Asp
Glu Lys Ala Gln
Glu Lys Gln Ala
Glu Leu Asp Val
Glu Leu Val Asp
Glu Gln Ala Lys
Glu Gln Lys Ala
Glu Val Asp Ile
Glu Val Asp Leu
Glu Val Glu Val
Glu Val Ile Asp
Glu Val Leu Asp
Glu Val Val Glu
Gly Gly Arg Trp
Gly Gly Trp Arg
Gly Arg Gly Trp
Gly Arg Trp Gly
Gly Trp Gly Arg
Gly Trp Arg Gly
Ile Asp Asp Ile
Ile Asp Asp Leu
Ile Asp Glu Val
Ile Asp Ile Asp
Ile Asp Leu Asp
Ile Glu Asp Val
Ile Glu Val Asp
Ile Ile Asp Asp
Ile Leu Asp Asp
Ile Asn Gln Thr
Ile Asn Thr Gln
Ile Gln Asn Thr
Ile Gln Gln Ser
Ile Gln Ser Gln
Ile Gln Thr Asn
Ile Ser Gln Gln
Ile Thr Asn Gln
Ile Thr Gln Asn
Ile Val Asp Glu
Lys Ala Glu Gln
Lys Ala Gln Glu
Lys Cys Pro Gln
Lys Cys Gln Pro
Lys Asp Asn Val
Lys Asp Val Asn
Lys Glu Ala Gln
Lys Glu Gln Ala
Lys Asn Asp Val
Lys Asn Val Asp
Lys Pro Cys Gln
Lys Pro Gln Cys
Lys Gln Ala Glu
Lys Gln Cys Pro
Lys Gln Glu Ala
Lys Gln Pro Cys
Lys Val Asp Asn
Lys Val Asn Asp
Leu Asp Asp Ile
Leu Asp Asp Leu
Leu Asp Glu Val
Leu Asp Ile Asp
Leu Asp Leu Asp
Leu Asp Val Glu
Leu Glu Asp Val
Leu Glu Val Asp
Leu Ile Asp Asp
Leu Leu Asp Asp
Leu Asn Gln Thr
Leu Asn Thr Gln
Leu Gln Asn Thr
Leu Gln Gln Ser
Leu Gln Ser Gln
Leu Gln Thr Asn
Leu Ser Gln Gln
Leu Thr Asn Gln
Leu Thr Gln Asn
Leu Val Asp Glu
Leu Val Glu Asp
Asn Asp Lys Val
Asn Asp Val Lys
Asn Ile Gln Thr
Asn Ile Thr Gln
Asn Lys Asp Val
Asn Lys Val Asp
Asn Leu Gln Thr
Asn Leu Thr Gln
Asn Gln Ile Thr
Asn Gln Leu Thr
Asn Gln Thr Ile
Asn Gln Thr Leu
Asn Thr Ile Gln
Asn Thr Leu Gln
Asn Thr Gln Ile
Asn Thr Gln Leu
Asn Val Asp Lys
Asn Val Lys Asp
Pro Cys Lys Gln
Pro Cys Gln Lys
Pro Lys Cys Gln
Pro Lys Gln Cys
Pro Pro Val Tyr
Pro Pro Tyr Val
Pro Gln Cys Lys
Pro Gln Lys Cys
Pro Val Pro Tyr
Pro Val Tyr Pro
Pro Tyr Pro Val
Pro Tyr Val Pro
Gln Ala Glu Lys
Gln Ala Lys Glu
Gln Cys Lys Pro
Gln Cys Pro Lys
Gln Glu Ala Lys
Gln Glu Lys Ala
Gln Ile Asn Thr
Gln Ile Gln Ser
Gln Ile Ser Gln
Gln Ile Thr Asn
Gln Lys Ala Glu
Gln Lys Cys Pro
Gln Lys Glu Ala
Gln Lys Pro Cys
Gln Leu Asn Thr
Gln Leu Gln Ser
Gln Leu Ser Gln
Gln Leu Thr Asn
Gln Asn Ile Thr
Gln Asn Leu Thr
Gln Asn Thr Ile
Gln Asn Thr Leu
Gln Pro Cys Lys
Gln Pro Lys Cys
Gln Gln Ile Ser
Gln Gln Leu Ser
Gln Gln Ser Ile
Gln Gln Ser Leu
Gln Gln Thr Val
Gln Gln Val Thr
Gln Ser Ile Gln
Gln Ser Leu Gln
Gln Ser Gln Ile
Gln Ser Gln Leu
Gln Thr Ile Asn
Gln Thr Leu Asn
Gln Thr Asn Ile
Gln Thr Asn Leu
Gln Thr Gln Val
Gln Thr Val Gln
Gln Val Gln Thr
Gln Val Thr Gln
Arg Gly Gly Trp
Arg Gly Trp Gly
Arg Trp Gly Gly
Ser Ile Gln Gln
Ser Leu Gln Gln
Ser Gln Ile Gln
Ser Gln Leu Gln
Ser Gln Gln Ile
Ser Gln Gln Leu
Thr Ile Asn Gln
Thr Ile Gln Asn
Thr Leu Asn Gln
Thr Leu Gln Asn
Thr Asn Ile Gln
Thr Asn Leu Gln
Thr Asn Gln Ile
Thr Asn Gln Leu
Thr Gln Ile Asn
Thr Gln Leu Asn
Thr Gln Asn Ile
Thr Gln Asn Leu
Thr Gln Gln Val
Thr Gln Val Gln
Thr Val Gln Gln
Val Asp Glu Ile
Val Asp Glu Leu
Val Asp Ile Glu
Val Asp Lys Asn
Val Asp Leu Glu
Val Asp Asn Lys
Val Glu Asp Ile
Val Glu Asp Leu
Val Glu Glu Val
Val Glu Ile Asp
Val Glu Leu Asp
Val Glu Val Glu
Val Ile Asp Glu
Val Ile Glu Asp
Val Lys Asp Asn
Val Lys Asn Asp
Val Leu Asp Glu
Val Leu Glu Asp
Val Asn Lys Asp
Val Pro Pro Tyr
Val Pro Tyr Pro
Val Gln Gln Thr
Val Gln Thr Gln
Val Thr Gln Gln
Val Val Glu Glu
Val Tyr Pro Pro
Trp Gly Gly Arg
Trp Gly Arg Gly
Trp Arg Gly Gly
Tyr Pro Pro Val
Tyr Pro Val Pro
Tyr Val Pro Pro
Austalide B
N-(4-CHLORO-3-NITROPHENYL)-4-(2,4-DI-TERT-PENTYLPHENOXY)BUTANAMIDE
2-[4-[4-(4-fluorophenyl)piperazin-1-yl]butyl]-1-(4-methoxyphenyl)indazol-3-one
A-740003
A-740003 is a potent, selective and competitive P2X7 receptor antagonist with IC50 values are 18 and 40 nM for rat and human P2X7 receptors, respectively.
N-{5-[Methoxy(phenyl)acetyl]-1,4,5,6-tetrahydropyrrolo[3,4-c]pyra zol-3-yl}-4-(4-methyl-1-piperazinyl)benzamide
danusertib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
XMD8-92
XMD8-92 is a potent ERK5 (BMK1)/BRD4 inhibitor with Kds of 80 and 190 nM, respectively. XMD8-92 inhibits DCAMKL2, PLK4 and TNK1 with Kds of 190, 600 and 890 nM, respectively. Anti-cancer activity[1][2].
1,4-bis[(2-ethyl-6-methylphenyl)amino]anthraquinone
Macimorelin
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C76358 - Growth Hormone-Releasing Hormone Analogue V - Various > V04 - Diagnostic agents > V04C - Other diagnostic agents > V04CD - Tests for pituitary function
4-[[11-hydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]oxy]-4-oxobutanoic acid
(3S)-1,2,3,6,7,7a,10,14,14abeta,14b-Decahydro-6alpha-hydroxy-3alpha,13-dimethoxy-5,5,7abeta,9,14balpha-pentamethyl-12H-3beta,5abeta-epoxy-5H-furo[3,4-i]oxepino[4,3-a]xanthen-12-one
Maackiaflavanone B
A dihydroxyflavanone that is (2S)-flavanone substituted by hydroxy groups at positions 5 and 7, prenyl groups at positions 8 and 3 and a 6,6-dimethyl-3,6-dihydro-2H-pyran ring fused across positions 4 and 5. Isolated from the stem barks of Maackia amurensis, it exhibits cytotoxicity against human cancer cell lines.
Mallotophilippen C
A member of the class of chalcones that is chalcone substituted by hydroxy groups at positions 4, 2 and 4, a geranyl group at position 3 and a 6,6-dimethyl-3,6-dihydro-2H-pyran ring fused across positions 5 and 6. Isolated from the fruits of Mallotus philippensis, it exhibits anti-inflammatory and immunoregulatory activities.
6-methoxy-3-[[[1-(2-oxolanylmethyl)-5-tetrazolyl]methyl-(2-phenylethyl)amino]methyl]-1H-quinolin-2-one
1-[2-(diethylamino)ethyl]-1-[(7-oxo-3,6-dihydro-2H-[1,4]dioxino[2,3-g]quinolin-8-yl)methyl]-3-(2-oxolanylmethyl)thiourea
Methyl 3-anilino-2-(1,7-dimethylindol-3-yl)-2,3-diphenylpropanoate
(4-fluorophenyl)-[(8R,9S,10R)-10-(hydroxymethyl)-9-[4-(3-methoxyphenyl)phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]methanone
(2S,3S,3aR,9bR)-3-(hydroxymethyl)-1-[(2-methoxyphenyl)methyl]-6-oxo-N-(2-pyridin-4-ylethyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
(2R,3R,3aS,9bS)-3-(hydroxymethyl)-1-[(2-methoxyphenyl)methyl]-6-oxo-N-(2-pyridin-4-ylethyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(2-thiazolylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(2-thiazolylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(2-thiazolylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(2-thiazolylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
(4-fluorophenyl)-[(8R,9S,10S)-10-(hydroxymethyl)-9-[4-(3-methoxyphenyl)phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]methanone
(4-fluorophenyl)-[(8S,9S,10S)-10-(hydroxymethyl)-9-[4-(3-methoxyphenyl)phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]methanone
(4-fluorophenyl)-[(8S,9R,10S)-10-(hydroxymethyl)-9-[4-(3-methoxyphenyl)phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]methanone
N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(2-thiazolylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
N-[(5R,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(2-thiazolylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
2-methoxy-N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-8-(4-oxazolylmethyl)-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
(4-fluorophenyl)-[(8S,9S,10R)-10-(hydroxymethyl)-9-[4-(3-methoxyphenyl)phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]methanone
(4-fluorophenyl)-[(8S,9R,10R)-10-(hydroxymethyl)-9-[4-(3-methoxyphenyl)phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]methanone
(4-fluorophenyl)-[(8R,9R,10S)-10-(hydroxymethyl)-9-[4-(3-methoxyphenyl)phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]methanone
(4-fluorophenyl)-[(8R,9R,10R)-10-(hydroxymethyl)-9-[4-(3-methoxyphenyl)phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]methanone
(1-acetyloxy-3-phosphonooxypropan-2-yl) (9Z,12Z,15Z)-octadeca-9,12,15-trienoate
(1-butanoyloxy-3-phosphonooxypropan-2-yl) (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate
BisMePA(18:3)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
mTOR inhibitor-3
mTOR inhibitor-3 is a remarkably selective mTOR inhibitor with a Ki of 1.5 nM. mTOR inhibitor-3 suppresses mTORC1 and mTORC2 in cellular and in vivo pharmacokinetic (PK)/pharmacodynamic (PD) experiments. mTOR inhibitor-3 is a remarkably selective mTOR inhibitor with a Ki of 1.5 nM. mTOR inhibitor-3 suppresses mTORC1 and mTORC2 in cellular and in vivo pharmacokinetic (PK)/pharmacodynamic (PD) experiments.
16-hydroxy-4-methoxy-2,6,14,17-tetramethyl-14-(5-oxooxolane-3-carbonyl)-10-oxatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadec-4-ene-3,11-dione
methyl (2s,4as,4bs,5s,6as,10as,10bs,12as)-5-hydroxy-2,4b,7,7,10a,12a-hexamethyl-12-methylidene-1,4,6,8-tetraoxo-hexahydro-4ah-phenanthro[1,2-c]pyran-2-carboxylate
(11r)-5,7,11-trihydroxy-2,2,9-trimethyl-10,12-bis(3-methylbut-2-en-1-yl)-11h-1-oxatetracen-6-one
4,8-bis(acetyloxy)-6,10,14-trimethyl-3-methylidene-2-oxo-3ah,4h,5h,8h,9h,12h,13h,15ah-cyclotetradeca[b]furan-12-yl acetate
6-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-5,7-dihydroxy-8-[(2r)-2-methylbutanoyl]-4-phenylchromen-2-one
(1r,13r)-6,6-dimethyl-10,16-bis(3-methylbut-2-en-1-yl)-7,12,20-trioxapentacyclo[11.8.0.0²,¹¹.0³,⁸.0¹⁴,¹⁹]henicosa-2,4,8,10,14(19),15,17-heptaene-9,17-diol
1,2-bis(acetyloxy)-4a-hydroxy-4,4,11b-trimethyl-7-methylidene-1h,2h,3h,5h,6h,6ah,11h,11ah-phenanthro[3,2-b]furan-3-yl acetate
1-methoxy-3-methyl-9-[(1s)-3,3,5-trimethyl-1h,2h,11h-pyrano[3,2-a]carbazol-1-yl]carbazole
5-[(1s,4r,5s,8r,9r,11r,12s,13r,14r,16r,18s)-5,11-dihydroxy-13-(hydroxymethyl)-9,16-dimethyl-15,17,20-trioxahexacyclo[14.3.1.1¹⁴,¹⁸.0¹,¹³.0⁴,¹².0⁵,⁹]henicosan-8-yl]pyran-2-one
(1r,2r,4s,16r,17r,20s)-2-hydroxy-13,20-dimethoxy-4,7,17,22,22-pentamethyl-5,10,21,23-tetraoxahexacyclo[18.2.1.0¹,¹⁷.0⁴,¹⁶.0⁶,¹⁴.0⁸,¹²]tricosa-6,8(12),13-trien-11-one
methyl (3r,4ar,4bs,5s,6as,10as,10bs,12ar)-5-hydroxy-3,4b,7,7,10a,12a-hexamethyl-12-methylidene-1,4,6,8-tetraoxo-hexahydro-3h-phenanthro[2,1-c]pyran-4a-carboxylate
5,12-bis(acetyloxy)-6-(hydroxymethyl)-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate
methyl (2s,4ar,4bs,5s,6ar,10as,10bs,12as)-5-hydroxy-2,4b,7,7,10a,12a-hexamethyl-12-methylidene-1,4,6,8-tetraoxo-hexahydro-4ah-phenanthro[1,2-c]pyran-2-carboxylate
6-(3,7-dimethylocta-2,6-dien-1-yl)-5,7-dihydroxy-8-(3-methylbutanoyl)-4-phenylchromen-2-one
(8r,9r,10r)-3,4,5,14,15,16-hexamethoxy-9,10-dimethyltricyclo[10.4.0.0²,⁷]hexadeca-1(12),2(7),3,5,13,15-hexaen-8-yl acetate
(1r,3as,3br,5as,7s,9r,9ar,9bs,11ar)-9a-formyl-3a,5a,7-trihydroxy-11a-methyl-1-(6-oxopyran-3-yl)-dodecahydro-1h-cyclopenta[a]phenanthren-9-yl acetate
(8s,9s,10r)-3,4,8,14,15,16-hexamethoxy-9,10-dimethyltricyclo[10.4.0.0²,⁷]hexadeca-1(12),2(7),3,5,13,15-hexaen-5-yl acetate
(1s,4s,7r,11r,12r)-14,16-dihydroxy-1,5,5-trimethyl-8-methylidene-12-phenyl-19-oxatetracyclo[9.8.0.0⁴,⁷.0¹³,¹⁸]nonadeca-13,15,17-triene-15,17-dicarbaldehyde
3-{3-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-4-hydroxy-5-(3-methylbut-2-en-1-yl)phenyl}-5,7-dihydroxychromen-4-one
5,7-dihydroxy-6-(2-methylbutanoyl)-8-[(e)-3,7-dimethylocta-2,6-dienyl]-4-phenyl-2h-chromen-2-one
{"Ingredient_id": "HBIN011284","Ingredient_name": "5,7-dihydroxy-6-(2-methylbutanoyl)-8-[(e)-3,7-dimethylocta-2,6-dienyl]-4-phenyl-2h-chromen-2-one","Alias": "NA","Ingredient_formula": "C30H34O5","Ingredient_Smile": "CCC(C)C(=O)C1=C(C2=C(C(=C1O)CC=C(C)CCC=C(C)C)OC(=O)C=C2C3=CC=CC=C3)O","Ingredient_weight": "474.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6017","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "11351972","DrugBank_id": "NA"}
5,7-dihydroxy-6-(3-methylbutanoyl)-8-[(e)-3,7-dimethylocta-2,6-dienyl]-4-phenyl-2h-chromen-2-one
{"Ingredient_id": "HBIN011286","Ingredient_name": "5,7-dihydroxy-6-(3-methylbutanoyl)-8-[(e)-3,7-dimethylocta-2,6-dienyl]-4-phenyl-2h-chromen-2-one","Alias": "NA","Ingredient_formula": "C30H34O5","Ingredient_Smile": "CC(C)CC(=O)C1=C(C2=C(C(=C1O)CC=C(C)CCC=C(C)C)OC(=O)C=C2C3=CC=CC=C3)O","Ingredient_weight": "474.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6018","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "21579160","DrugBank_id": "NA"}
5,7-dihydroxy-8-(2-methylbutanoyl)-6-[(e)-3,7-dimethylocta-2,6-dienyl]-4-phenyl-2h-chromen-2-one
{"Ingredient_id": "HBIN011297","Ingredient_name": "5,7-dihydroxy-8-(2-methylbutanoyl)-6-[(e)-3,7-dimethylocta-2,6-dienyl]-4-phenyl-2h-chromen-2-one","Alias": "NA","Ingredient_formula": "C30H34O5","Ingredient_Smile": "CCC(C)C(=O)C1=C(C(=C(C2=C1OC(=O)C=C2C3=CC=CC=C3)O)CC=C(C)CCC=C(C)C)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6019","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
5,7-dihydroxy-8-(3-methylbutanoyl)-6-[(e)-3,7-dimethylocta-2,6-dienyl]-4-phenyl-2h-chromen-2-one
{"Ingredient_id": "HBIN011298","Ingredient_name": "5,7-dihydroxy-8-(3-methylbutanoyl)-6-[(e)-3,7-dimethylocta-2,6-dienyl]-4-phenyl-2h-chromen-2-one","Alias": "NA","Ingredient_formula": "C30H34O5","Ingredient_Smile": "CC(C)CC(=O)C1=C(C2=C(C(=C1O)CC=C(C)CCC=C(C)C)OC(=O)C=C2C3=CC=CC=C3)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6020","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}